This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 NovemberAustria Center Vienna
Register Now
Menu
Book Now

Nicholas Ede, PhD
Chief Technology Officer at Imugene

Agenda Sessions

  • Development of the B Cell Cancer Vaccine HER-Vaxx for the Treatment of Her-2 Expressing Cancers

    , 11:00
    View Session

Speakers at this event

Prev
Next
J. William Efcavitch, PhD
Co-Founder & Chief Scientific Officer
Molecular Assemblies

See Nicholas Speak

Register Now